Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 51 - 60 of 688 shown below

  • O'Brien, L

    P Myles, S Evans, A Lophatananon, P Dimitropoulou, D Easton, T Key, R Pocock, D Dearnaley, M Guy, S Edwards, L O'Brien, B Gehr-Swain, A Hall, R Wilkinson, R Eeles and K Muir

    Diagnostic radiation procedures and risk of prostate cancer

    advance online publication, 2008-05-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604370

    Abstract | Full article | PDF

  • Z Kote-Jarai, S Jugurnauth, S Mulholland, D A Leongamornlert, M Guy, S Edwards, M Tymrakiewitcz, L O'Brien, A Hall, R Wilkinson, A A Al Olama, J Morrison, K Muir, D Neal, J Donovan, F Hamdy, D F Easton and R Eeles

    A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer

    advance online publication, 2009-01-06 00:00:00.000;

    doi:10.1038/sj.bjc.6604847

    Abstract | Full article | PDF

  • O'Brien, M

    J Bennouna, J-L Breton, J-M Tourani, C Ottensmeier, M O'Brien, P Kosmidis, T E Huat, M-C Pinel, C Colin and J-Y Douillard

    Vinflunine – an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study

    advance online publication, 2006-04-25 00:00:00.000;

    doi:10.1038/sj.bjc.6603106

    Abstract | Full article | PDF

  • L Paz-Ares, H Ross, M O'Brien, A Riviere, U Gatzemeier, J Von Pawel, E Kaukel, L Freitag, W Digel, H Bischoff, R García-Campelo, N Iannotti, P Reiterer, I Bover, J Prendiville, A J Eisenfeld, F B Oldham, B Bandstra, J W Singer and P Bonomi

    Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

    advance online publication, 2008-05-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604372

    Abstract | Full article | PDF

  • R L Jones, G Walsh, S Ashley, S Chua, R Agarwal, M O'Brien, S Johnston and I E Smith

    A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer

    doi:10.1038/sj.bjc.6604862

    Abstract | Full article | PDF

  • O'Brien, M E R

    T Yau, S Ashley, S Popat, A Norton, A Matakidou, J Coward and M E R O'Brien

    Time and chemotherapy treatment trends in the treatment of elderly patients (age greater than or equal to70 years) with small cell lung cancer

    advance online publication, 2005-11-29 00:00:00.000;

    doi:10.1038/sj.bjc.6602888

    Abstract | Full article | PDF

  • M E R O'Brien, A Borthwick, A Rigg, A Leary, L Assersohn, K Last, S Tan, S Milan, D Tait and I E Smith

    Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients

    doi:10.1038/sj.bjc.6603498

    Abstract | Full article | PDF

  • O'Brien, P M

    V A Heinzelmann-Schwarz, M Gardiner-Garden, S M Henshall, J P Scurry, R A Scolyer, A N Smith, A Bali, P Vanden Bergh, S Baron-Hay, C Scott, D Fink, N F Hacker, R L Sutherland and P M O'Brien

    A distinct molecular profile associated with mucinous epithelial ovarian cancer

    advance online publication, 2006-02-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603003

    Abstract | Full article | PDF

  • P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton, M J Henderson, D N Saunders, B S Gloss, K I Patterson, J L Clancy, V A Heinzelmann-Schwarz, R A Scolyer, Y Zeng, E D Williams, L Scurr, A DeFazio, D I Quinn, C K W Watts, N F Hacker, S M Henshall and R L Sutherland

    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

    advance online publication, 2008-03-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604281

    Abstract | Full article | PDF

  • P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton, M J Henderson, D N Saunders, B S Gloss, K I Patterson, J L Clancy, V A Heinzelmann-Schwarz, R Murali, R A Scolyer, Y Zeng, E D Williams, L Scurr, A DeFazio, Di Quinn, C K W Watts, N F Hacker, S M Henshall and R L Sutherland

    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

    doi:10.1038/sj.bjc.6604419

    Abstract | Full article | PDF

  • O'Brien, T J

    H Tanimoto, K Shigemasa, X Tian, L Gu, J B Beard, T Sawasaki and T J O'Brien

    Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer

    advance online publication, 2004-12-21 00:00:00.000;

    doi:10.1038/sj.bjc.6602320

    Abstract | Full article | PDF

  • O'Brien, V

    L C Scott, T R J Evans, J Cassidy, S Harden, J Paul, R Ullah, V O'Brien and R Brown

    Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response

    advance online publication, 2009-07-14 00:00:00.000;

    doi:10.1038/sj.bjc.6605175

    Abstract | Full article | PDF

  • O'Byrne, J

    J Glaspy, J Singh Jadeja, G Justice, J Kessler, D Richards, L Schwartzberg, J Rigas, D Kuter, D Harmon, D Prow, G Demetri, D Gordon, J Arseneau, A Saven, H Hynes, R Boccia, J O'Byrne and A B Colowick

    A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

    doi:10.1054/bjoc.2001.1748

    Abstract | Full article | PDF

  • O'Byrne, K

    C M Gillham, J A Lucey, M Keogan, G J Duffy, V Malik, A A Raouf, K O'Byrne, D Hollywood, C Muldoon and J V Reynolds

    18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response

    advance online publication, 2006-10-03 00:00:00.000;

    doi:10.1038/sj.bjc.6603412

    Abstract | Full article | PDF

  • O'Callaghan, G

    G O'Callaghan, J Kelly, F Shanahan and A Houston

    Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells

    advance online publication, 2008-07-22 00:00:00.000;

    doi:10.1038/sj.bjc.6604490

    Abstract | Full article | PDF

  • O'Connell, D L

    X Q Yu, D L O'Connell and D Forman

    Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites

    advance online publication, 2004-10-12 00:00:00.000;

    doi:10.1038/sj.bjc.6602154

    Abstract | Full article | PDF